EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation

Yonghua Xu, Yunting Zou, Shasha Zhou, Miao-Miao Niu, Yan Zhang, Jindong Li, Zhen Xu, Li Yang

Journal of Enzyme Inhibition and Medicinal Chemistry · 2023

DOI: 10.1080/14756366.2023.2220558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. Verfasst von Yonghua Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nantong First People's Hospital, Nantong, China. Hauptthemen laut MEDLINE: Drug Discovery, HSP90 Heat-Shock Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Research Hospital Association for Precision Medication, Fengcheng Talent Plan Youth Science and Technology Talent Recruitment Project of Taizhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heat shock protein 90 (Hsp90) is considered an attractive therapeutic target for cancer treatment due to its high expression in many cancers. In this study, four potent Hsp90 inhibitors (HPs 1-4) were identified using structure-based virtual screening. Among them, HP-4 exhibited the most potent inhibitory effects (IC50 = 17.64 ± 1.45 nM) against the Hsp90 protein, which was about 7.7 times stronger than that of MPC-3100 (a positive inhibitor targeting Hsp90). In vitro cytotoxicity assay suggested that HP-4 could effectively inhibit the proliferation of a series of tumour cells, including HCT-116, HeLa, A549, A2780, DU145, HepG2 and A498. Furthermore, in vivo assay displayed that HP-4 had significant anti-tumour effects on HCT-116 cell-derived xenograft models. These data demonstrate that HP-4 could be a potential lead compound for the further investigation of anti-tumour drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryHSP90 Heat-Shock ProteinsCell Line, TumorDrug Evaluation, PreclinicalMice, Inbred BALB CMice, NudeMolecular Docking SimulationPharmacophoreHumansAnimalsMice

Stichwörter der Autor:innen

Hsp90biological evaluationcolon cancerinhibitorvirtual screening

Substanzen

HSP90 Heat-Shock Proteins

Autor:innen und Institutionen

  • Department of Pharmacy, Nantong First People's Hospital, Nantong, China.
  • Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.
  • Department of Oncology, Urology and Pharmacy, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.

Förderung

  • Jiangsu Research Hospital Association for Precision Medication
  • Fengcheng Talent Plan Youth Science and Technology Talent Recruitment Project of Taizhou

Zitieren

APA

Xu, Y., Zou, Y., Zhou, S., Niu, M. M., Zhang, Y., Li, J., Xu, Z., & Yang, L. (2023). Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2023.2220558

Vancouver

Xu Y, Zou Y, Zhou S, Niu MM, Zhang Y, Li J, et al. Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 2023. doi:10.1080/14756366.2023.2220558

BibTeX
@article{Xu2023,
  author = {Xu, Yonghua and Zou, Yunting and Zhou, Shasha and Niu, Miao-Miao and Zhang, Yan and Li, Jindong and Xu, Zhen and Yang, Li},
  title = {Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2023},
  doi = {10.1080/14756366.2023.2220558}
}
Kostenlos starten →